Harbor Entrepreneur Center gains new leader see more
The Harbor Entrepreneur Center, a nonprofit focused on helping entrepreneurs through accelerator programs and coworking spaces, will have a new executive director on June 1.
Daniel Stern, the former executive director of the Jewish Community Center and previous major gifts officer for the Lowcountry Food Bank, will assume the helm. John Osborne, the Harbor’s co-founder and current executive director, said recently he plans to step down to work fulltime at Good Growth Capital, a Charleston-based venture capital fund, and with Charleston Angel Partners, an area investment group. “The Harbor is heading into a phase of rapid growth and we are excited to have Daniel on board to lead our nonprofit,” said Osborne, who will sit on the board.
SCBIO's Charleston-area office is graciously hosted at The Harbor Entrepreneur Center by the non-profit organization.
22 WESTEDGE BREAKS GROUND AND BREAKS THE MOLD FOR INNOVATIVE LIFE SCIENCES WORKPLACES IN CHARLESTON, SCNEW LIFE SCIENCES DISTRICT KICKS OFF CONSTRUCTION IN CHARLESTON, SC AT WESTEDGE see more
Charleston, SC - July 17, 2018 marked the construction kickoff for 22 WestEdge, a striking new workplace anchor for the city’s growing knowledge economy and the highly anticipated centerpiece of the WestEdge District. The iconic 125-foot, eight-story structure will be the tallest multi-tenant office building on the peninsula and in Charleston’s metropolitan area when it opens in November 2019.
“22 WestEdge affirms the vision for a Live, Learn and Earn district, adding vital office, research and lab components to the world class WestEdge community. It builds on the remarkable momentum of a development that already has over $300 million under construction,” said Michael Maher, CEO of The WestEdge Foundation, Inc., the non-profit sponsor of the overall development.
Even prior to the 22 WestEdge groundbreaking, area economic development proponents including The Medical University of South Carolina, the South Carolina Research Authority, the City of Charleston, Heritage Trust and the WestEdge Foundation committed to 22 WestEdge, forming the nucleus of entities working to incubate, attract and retain entrepreneurial talent to energize the Charleston economy. While 48% of the space is currently leased, 72,000 square feet of office space and 10,000 square feet of retail space remain available for existing local businesses, or for new companies being created or relocating to the Charleston region. This is a remarkable concentration of ingenuity¾over 35,000 people live, work, study and seek healthcare expertise in the adjacent medical district.
Partnership and innovation opportunities abound for 22 WestEdge tenants—with unprecedented access to like-minded neighbors and colleagues in Charleston’s life sciences sector. Dr. David Cole, President of MUSC shared, “With MUSC’s $275 million of research and proprietary discoveries, 22 WestEdge will allow the University to collaborate with private industry to create new healthcare solutions, new companies and recruit existing global medical-related companies to Charleston.” Bob Quinn, Executive Director of the SCRA agreed, “SCRA’s leasing of the entire top floor of 22 WestEdge will allow us to create a world-class facility, including laboratories, which will serve as a catalyst for the attraction of leading life sciences companies and the creation of a Discovery District adjacent to MUSC.”
Charleston Mayor John Tecklenburg echoed, “It’s no secret that biomedical advances will be a key driver of our economy and society in the years ahead. With 156,000 square feet of office space dedicated to precisely the kind of research and enterprise that will help make those breakthroughs possible, 22 WestEdge is a welcome and important addition to our city’s medical district.”
22 WestEdge office tenants will also benefit from the energy and vitality of the district. Recently completed, The Caroline has 237 apartments and 20,000 square feet of retail and restaurant space, and the topped-out 10 WestEdge will have 350 residential units, a Publix Super Market, Woodhouse Spa and additional retail and restaurant space, providing an abundance of shopping, eating and living options for all. 22 WestEdge’s own amenities include 15,000 square feet of cafes and fitness facilities, common conference and event facilities and a terrace wrapping the 7th floor with sweeping views of the Ashley River. Mack Reese, 22 WestEdge developer and partner, explains his reason for developing the project, “With its access to parking, numerous retail amenities and an urban density of residential opportunities for employees, the building will be a new and exciting option for existing Charleston businesses and those looking to relocate to the region.”
Upon completion, WestEdge’s master-planned mixed-use district will encompass more than 3,000,000 square feet of space on 60 acres along the Ashley River adjacent to MUSC and the Medical District, and fronting on Brittlebank Park and the Joseph Riley Baseball Stadium. WestEdge is a public-private partnership created to advance economic development and expand the research capabilities of the Medical University of South Carolina and foster new companies and collaborative opportunities with private industry. It is an innovative redevelopment that is transforming the quality of life for Charleston’s west side.
Key 22 WestEdge partners include Gateway Development (Developer) ELV Associates (Investor), BB&T (Lender), Trident Construction (General Contractor), Perkins & Will (Architect), Thomas and Hutton (Civil Engineer), and Lee & Associates (Marketing & Leasing).
For leasing inquiries and further detail on WestEdge development, please contact Mack Reese of Gateway Development (770-310-3414 ).
Lita Nelsen named to MUSC Foundation of Research Development Board see more
CHARLESTON, S.C. (May 7, 2018) – The Medical University of South Carolina (MUSC) Foundation of Research Development (FRD) has elected Lita Nelsen to its board of directors. An international expert in university technology transfer, Nelsen was elected as an at-large member and began her three-year term April 2018.
“I am honored and excited to be part of the MUSC FRD board as it is embarking on an enhanced effort to bring the results of MUSC research to patients through licensing of patents and new software, collaborative research with industry, and formation of new startup companies based on MUSC research results,” she said. “The benefits will extend far beyond MUSC itself, to patients, to companies, and to economic development of the region.”
Having served as Director of the Technology Licensing Office at the Massachusetts Institute of Technology (MIT) for nearly 30 years, Nelsen brings a wealth of unprecedented technology transfer experience to MUSC. Currently she works as a consultant in licensing, university technology transfer and entrepreneurship in the US, Europe and Asia.
FRD board chair Arlene Morris said, “It is a pleasure to welcome Lita to the MUSC FRD Board. Her vast experience with innovation, licensing and consulting will bring a dimension to MUSC that will be helpful as we transition our science to help patients and healthcare providers improve therapies.”
Amy Salzhauer, managing partner of Charleston-based Good Growth Capital adds, “I had the good fortune of working with Lita when I was starting companies out of MIT; her leadership was an essential part of the development of the entrepreneurial ecosystem at MIT for several decades. She is a legend in her field. I am so excited she is bringing her unparalleled expertise and experience to MUSC and to South Carolina.”
Nelsen completed bachelor’s and master’s degrees in chemical engineering from MIT, as well as earning a master’s degree in management from MIT as a Sloan fellow. Before her position at MIT, she spent 20 years in industry, primarily in the fields of membrane separations, medical devices, and biotechnology.
She is widely published, has lectured in and advised universities in at least 20 countries, and has served on many boards including as president of the Association of University Technology. She was also on the board of Mass Ventures (MTDC) for 20 years, and is currently on the scientific advisory boards of Partners’ Investment Fund and the Massachusetts Life Sciences Center. The United Kingdom’s government awarded her the honor of “Member of the Order of the British Empire” (MBE) for her work with technology transfer institutions throughout the UK.
“Over the past several years we have recruited some of the best technology transfer, industry, and venture capital talent to the FRD Board. We are grateful to have Ms. Nelsen join us and it exemplifies MUSC’s commitment to the commercialization our technologies, “said Michael Rusnak, MUSC FRD executive director.
About the MUSC Foundation for Research Development
MUSC Foundation for Research Development (FRD) has served as MUSC's technology transfer office since 1998. During that period, FRD has filed patent applications on more than 400 technologies, resulting in over 150 U.S. issued patents. Additionally, FRD has executed more than 150 licenses and spun out more than 50 startup companies. MUSC startups have had products approved by the FDA and acquired by publicly traded corporations while attracting substantial investment dollars into South Carolina. Innovations from MUSC, including medical devices, therapies and software, are positively impacting health care worldwide. Please visit us online at http://frd.musc.edu/
Founded in 1824 in Charleston, The Medical University of South Carolina is the oldest medical school in the South. Today, MUSC continues the tradition of excellence in education, research, and patient care. MUSC educates and trains more than 3,000 students and 700 residents in six colleges (Dental Medicine, Graduate Studies, Health Professions, Medicine, Nursing, and Pharmacy), and has nearly 14,000 employees, including approximately 1,500 faculty members. As the largest non-federal employer in Charleston, the university and its affiliates have collective annual budgets in excess of $2.4 billion, with an annual economic impact of more than $3.8 billion and annual research funding in excess of $250 million. MUSC operates a 700-bed medical center, which includes a nationally recognized children's hospital, the Ashley River Tower (cardiovascular, digestive disease, and surgical oncology), Hollings Cancer Center (a National Cancer Institute-designated center), Level I trauma center, Institute of Psychiatry, and the state’s only transplant center. In 2017, for the third consecutive year, U.S. News & World Report named MUSC Health the number one hospital in South Carolina. For more information on academic programs or clinical services, visit musc.edu. For more information on hospital patient services, visit muschealth.org.
A Charleston neighborhood is being transforned into a hotbed for life sciences firms see more
A plan from the early 2000s to transform part of Charleston’s Westside neighborhood into a hotbed for life sciences firms, medical device companies and innovative medical research is now in motion.
A large-scale development known as WestEdge is in the works on land bounded by Lockwood Boulevard, Fishburne Street, Hagood Avenue and Spring Street. A few hotels and office buildings, Brittlebank Park, Joseph P. Riley Jr. Park and expansive gravel parking lots dot that part of the Westside today.
South Carolina universities are making huge strides in designing better operating rooms for doctors see more
In an effort to design an operating room that increases patient safety and is easier for doctors to use, MUSC has been working with Clemson University on a four-year research project, which began in 2015, to study how doctors maneuver around operating rooms. Now the fruits of their talents and efforts are paying off. Read the full story.
MED-ALLY is growing! The organization is locating new operations in South Carolina... see more
COLUMBIA, S.C. – MED-ALLY, a privately-held medical device manufacturer, is locating new operations in Berkeley County. The $2.38 million investment is expected to create 90 new jobs.
MED-ALLY is an innovative design, development and manufacturing company specializing in active implantable medical systems. The company has designed and developed VersaStim® neuromodulation platform technology, which treats patients with movement disorders, spinal cord injuries, chronic pain and traumatic brain injuries. The VersaStim® technology platform is available in external and implantable systems for clinicians to maximize therapy effectiveness and improve patient outcomes.
The company’s state-of-the-art, 10,000-square-foot manufacturing operation will be located in the Charleston International Manufacturing Center at 2040 Bushy Park Road in Goose Creek, S.C. An ISO Class 6 Clean Room, critical for the fabrication of implantable devices, will take up approximately half of the operating space. Expected to be fully operational in March 2018, MED-ALLY is already hiring for its new technical positions. Those interested in joining the team should visit www.med-ally.com(link is external).
The Coordinating Council for Economic Development has approved job development credits related to this project.
“We are indeed fortunate for the opportunity to join the many successful and class-leading companies that call the Lowcountry and Charleston home, and can only aspire to one day approach a close enough level of similar lofty accomplishments! Through the professional South Carolina organizations and wonderful associates at every level at the CRDA, SCRA, SCBIO, S.C. Commerce and others, more akin to treasured business partners over all else, we believe that we are surrounding ourselves with an enabling, empowering and conducive team like no other. We look forward to growing and prospering in Berkeley County amidst its wonderful constituency and leadership team.” –MED-ALLY, LLC CEO and Co-Founder Raja Edward Hitti
“We are excited to join the growing South Carolina medical device community and deliver innovative bioelectronic products that positively impact the global Healthcare market. The MED-ALLY team is looking forward to working with distinguished clinicians, university medical teams, industry partners and university students dedicated to providing disruptive medical device solutions to treat debilitated patients worldwide.” –MED-ALLY, LLC President and Co-Founder John Mulvihill
“It’s always exciting when a company decides to locate new operations in South Carolina, and we’re pleased to welcome such an innovative firm that’s focused on cutting-edge advanced manufacturing. I congratulate them on this new investment and can’t wait to see what the future has in store for them here.” –Gov. Henry McMaster
“The life sciences industry is one that presents significant growth opportunities for South Carolina, and today’s announcement by MED-ALLY is proof of that. I congratulate this innovative company and wish them much success in the Lowcountry.” –Secretary of Commerce Bobby Hitt
“MED-ALLY’s announcement of its medical device manufacturing project in the Lowcountry is extremely exciting for Berkeley County; we are honored to welcome MED-ALLY, their investment and the 90 technical jobs they offer. MED-ALLY’s announcement is also further proof that Berkeley County is open for business, and Berkeley County means business. Through meetings with the company’s team, I am confident MED-ALLY will thrive in Berkeley County and also be incredible partners in job creation opportunities for many years to come.” –Berkeley County Supervisor Bill Peagler
“We’ve been talking with MED-ALLY for some time about the competitive advantages the Charleston region offers, and we’re thrilled our community successfully competed against much larger U.S. metros to attract this implantable medical device manufacturer to locate its headquarters, R&D and manufacturing facility in Berkeley County. We are proud to welcome MED-ALLY to Charleston’s growing life sciences cluster. They will be a tremendous asset for many years to come.” –Charleston Regional Development Alliance Chairman Will Helmly
FIVE FAST FACTS
- MED-ALLY is locating new manufacturing operations in Berkeley County.
- $2.38 million investment to create 90 new jobs.
- MED-ALLY is a personalized health solutions company dedicated to manufacturing medical devices.
- Located at 2040 Bushy Park Road in Goose Creek, S.C., the company’s new facility is projected to be operational in March 2018.
- Those interested in joining the MED-ALLY team should visit www.med-ally.com(link is external).
SCBIO has named Erin Ford as the organization's first VP see more
SCBIO’s executive committee announced today that Erin Ford, currently the director of sales at Anderson-based Poly-Med Inc. and Chair of the Board of Directors of the South Carolina Biotechnology Industry Organization (SCBIO), is joining the non-profit life sciences industry organization as its inaugural Vice President.
SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry already has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products. The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries.
“Erin is an extraordinarily talented, multi-faceted executive with magnetic relationship-building skills, along with being a proven leader,” said SCBIO President/CEO, Sam Konduros. “As I was vetting and interviewing a number of extremely worthy candidates for this critical executive position, it occurred to me that our board chair was the absolute perfect fit, and I felt humbly compelled to ask Erin to consider exploring the role. To my and the Executive Committee’s great delight, she ultimately committed to bring her signature career to SCBIO on a full-time basis starting January 2nd. We are extremely fortunate to have such a knowledgeable and seasoned pro like Erin join the executive team and hit the ground running in 2018, following a year of her outstanding leadership as our board chair.”
Ms. Ford departs Poly-Med, a global innovation company that is developing absorbable polymers and constructs for the medical device industry, for her new role at SCBIO, where she will work closely with the CEO on various corporate strategies emanating from the organization’s 3 statewide offices. Her comprehensive responsibilities will include serving as primary lead for SCBIO’s business operations, championing investor relations and existing industry strategies, and spearheading major integrated marketing initiatives.
She previously served as a business recruitment officer at the Upstate SC Alliance, where she was the main point of contact for life sciences companies interested in expanding or locating in Upstate South Carolina, and gained in-depth economic development experience. While at the Upstate Alliance, Ms. Ford served as an ex-officio SCBIO board member from 2013-2015, and led a regional biosciences task force comprised of industry executives from across the region. She also has extensive television experience as a documentary producer and sportscaster, and received her B.A. in Communication from La Salle University in Philadelphia.
"SCBIO presents a unique career opportunity to work in an arena whose constituent members and companies make a tangible difference in the quality of people's lives," said Ms. Ford. "Our hundreds of members include academic institutions, biotech companies, service providers, thought leaders, and economic development groups whose members are leading the research and development of innovative healthcare, industrial and environmental biotechnology and med-tech products that can transform and extend people’s lives. While I have loved my time at Poly-Med, which served as an invaluable life science industry experience for my new career path with SCBIO, this unique opportunity to touch lives and grow South Carolina's knowledge economy was simply too powerful to pass up."
Ms. Ford joins SCBIO's recently named President and CEO Sam Konduros atop the growing organization's leadership team. Konduros, also a former SCBIO board member, assumed the leadership reins of the group earlier this year after departing Greenville Health System, where he ran the Research Development Corporation forging industry partnerships, developing economic development strategies, and helping doctors take their inventions to market. Previously, he was the first president of the Upstate SC Alliance, the Upstate region’s economic-development agency.
The addition of Ms. Ford occurs as SCBIO continues to flex new muscles to advance and grow the business of life sciences in South Carolina. It comes on the heels of the organization's recent restructuring and rebranding efforts, and its highly successful annual conference, which drew hundreds of industry leaders, national executives, academics, economic development organizations, government officials and others to Charleston October 24-26. The organization has already attained record membership and investor levels, and recently formed a partnership with the South Carolina Department of Commerce to develop and implement strategic growth recommendations for the state’s fast-expanding industry.
"This industry is at a critical time for accelerating our growth and impact in South Carolina and well beyond," said Ms. Ford. "When you have such a unique opportunity, you have to seize the day and make positive things happen. That's our goal."
SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations. SCBIO members include academic institutions, biotech companies, med-tech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.
Eight story office and lab building named 22 WestEdge breaks ground in Charleston, SC see more
The third multistory building set to rise in the developing WestEdge community on the Charleston peninsula broke ground Thursday — under a tent because of all the recent rain.
The eight-story office and laboratory structure called 22 WestEdge will sit next to the under-construction, nine-story 10 WestEdge building at Spring Street and Lockwood Drive. That’s where Publix supermarket is set to open on the ground floor in October.
The first floor of the all-glass exterior structure will house 15,750 square feet of retail space while the upper floors will provide 138,500 square feet of office space-targeted firms in the so-called knowledge economy, such as the life sciences industry. About half of the site has already been leased.